Impact of chemotherapy treatment on the quality of life of patients with cancer

被引:1
作者
Silveira, Fernanda Modesto [1 ]
Wysocki, Anneliese Domingues [1 ]
Mendez, Roberto Della Rosa [1 ]
Pena, Silvana Barbosa [1 ]
dos Santos, Edirlei Machado [1 ]
Malaguti-Toffano, Silmara [2 ]
dos Santos, Vinicius Batista [3 ]
dos Santos, Mariana Alvina [1 ]
机构
[1] Univ Fed Mato Grosso do Sul, Tres Lagoas, MS, Brazil
[2] Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil
[3] Univ Fed Sao Paulo, Escola Paulista Enfermagem, Sao Paulo, SP, Brazil
关键词
Quality of life; Neoplasms; Chemotherapy; adjuvante; DIAGNOSIS; QLQ-C30; FATIGUE;
D O I
10.37689/acta-ape/2021AO00583
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: To assess the health-related quality of life (HRQoL) of patients with cancer before and three months after starting chemotherapy treatment. Methods: This is a prospective and exploratory cohort study. An instrument was used for sociodemographic and clinical characterization of patients and another for assessing HRQoL called EORTC QLQ-C30. This instrument consists of functional, symptom, and global health status scales. Seventy-nine individuals attended at an outpatient clinic for chemotherapy. Statistical tests were performed to compare side effects of chemotherapy treatment on quality of life. Results: The EORTC QLQ-C30 indicated adequate reliability in two assessment moments. Concerning the functional scale, physical functioning and cognitive functioning improved, and emotional functioning worsened after three months of treatment. The symptom scale worsened three months after starting chemotherapy with respect to the symptoms of fatigue, nausea, dyspnea, appetite loss, and diarrhea. Conclusion: The most affected domains, after three months of chemotherapy treatment, were related to functional and symptom scales' functioning; therefore, multidisciplinary interventions should be implemented for this population in order to control such variables.
引用
收藏
页数:9
相关论文
共 30 条
  • [11] Ferreira Maria Luiza Ludermir, 2015, Rev. bras. geriatr. gerontol., V18, P165, DOI 10.1590/1809-9823.2015.14008
  • [12] Floriano D.F., 2017, REV ODONTOL U CID SA, V29, P230, DOI [10.26843/ro_unicidv2932017p230-236, DOI 10.26843/RO_UNICIDV2932017P230-236]
  • [13] Garcia SN, 2017, REV BAIANA ENFERM, V31
  • [14] Gomes RA, 2018, REV ENFERM UFPE, V12, P1200
  • [15] Cancer-related fatigue: The scale of the problem
    Hofman, Maarten
    Ryan, Julie L.
    Figueroa-Moseley, Colmar D.
    Jean-Pierre, Pascal
    Morrow, Gary R.
    [J]. ONCOLOGIST, 2007, 12 : 4 - 10
  • [16] INCA, 2020, INC CANC BRAS
  • [17] Instituto Nacional de Cancer (INCA), 2018, PREV FAT RISC PREV FAT RISC
  • [18] Instituto Nacional de Cancer (INCA), 2019, QUE CANC
  • [19] A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Clinical Trial of the Effect of Modafinil on Cancer-Related Fatigue Among 631 Patients Receiving Chemotherapy
    Jean-Pierre, Pascal
    Morrow, Gary R.
    Roscoe, Joseph A.
    Heckler, Charles
    Mohile, Supriya
    Janelsins, Michelle
    Peppone, Luke
    Hemstad, Amy
    Esparaz, Benjamin T.
    Hopkins, Judith O.
    [J]. CANCER, 2010, 116 (14) : 3513 - 3520
  • [20] Mansano-Schlosser TC, 2016, ACTA PAUL ENFERM, V29, P595